ArticleAmerican journal of hematology2025
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.
Abstract read
In one paragraph
Article in American journal of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guideline
- Letter to the Editor Regarding "Impact of COVID-19 on Hematologic Cancer Patients: Insights From the Late Pandemic Phase".Cancer medicine · 2026Article
- 30 years in service, 1996-2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Annals of hematology · 2026Review
- Risk Factors for Mortality Associated With Influenza Infection in Patients With Hematologic Malignancies: A Cross-Sectional Descriptive Observational Study.Health science reports · 2026Article
- Clinical distribution and drug resistance of carbapenem-resistant Pseudomonas aeruginosa infection in Eastern China from 2019 to 2024.BMC infectious diseases · 2026Article
- Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry.Open forum infectious diseases · 2026Article
- Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry.American journal of hematology · 2026Article
- Influenza virus research in an era of emerging respiratory threats: host-virus interactions, surveillance technologies, antiviral management and resistance, and vaccine preparedness.Frontiers in microbiology · 2026Review
- Drug-resistant tuberculosis and pulmonary co-infections in immunocompromised patients: from multi-omics to precision therapy.Frontiers in microbiology · 2026Review
- Prolonged SARS-CoV-2 infection in hematologic malignancies: clinical impact, risk factors and intra-host viral evolution.Frontiers in immunology · 2026Observational
- Severity of Respiratory Syncytial Virus and Other Respiratory Viruses Versus Seasonal Influenza Among Hospitalized Patients With Cancer.Open forum infectious diseases · 2025Article
- Role of remdesivir for the treatment of COVID-19 in patients with hematologic malignancy-A narrative review and expert opinion.European journal of clinical investigation · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
100 authors.
Jon Salmanton-GarcíaFaculty of Medicine, University of Cologne and University Hospital Cologne, Institute of Translational Research, Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.ORCID 0000-0002-6766-8297
Francesco MarchesiHematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID 0000-0001-6353-2272
Milan NavrátilDepartment of Haematooncology, University Hospital Ostrava, Ostrava, Czech Republic.
Klára PiukovicsDepartment of Hematology, South Division of Internal Medicine Clinic, Albert Szent-Györgyi Health Center, University of Szeged, Szeged, Hungary.
Maria Ilaria Del PrincipeHematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Marianna CriscuoloHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.ORCID 0000-0001-5661-2338
Yavuz M BilginDepartment of Internal Medicine, ADRZ, Goes, Netherlands.ORCID 0000-0002-3783-3407
Nicola S FracchiollaHematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-8982-8079
Antonio VenaDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Alessandra RomanoAOU Policlinico Rodolico San Marco, Catania, Italy.ORCID 0000-0002-6333-4433
Iker Falces-RomeroMicrobiology and Parasitology Department, University Hospital La Paz, Madrid, Spain.
Nicola SgherzaHematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.ORCID 0000-0001-5447-1068
Inmaculada Heras-FernandoDepartment of Hematology and Oncology, Hospital Morales Messeguer, Murcia, Spain.
Monika M BiernatDepartment of Hematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland.ORCID 0000-0003-3161-3398
Verena PetzerDepartment of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.ORCID 0000-0002-9205-1440
Pavel ŽákUniversity Hospital Hradec Králové, Hradec Králové, Czech Republic.
Barbora WeinbergerováDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
Michail SamarkosLaikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Nurettin ErbenDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Jens van PraetDepartment of Nephrology and Infectious Diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium.
Alberto López-GarcíaFundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.ORCID 0000-0002-5354-5261
Jorge LabradorDepartment of Hematology, Research Unit, Hospital Universitario de Burgos, Burgos, Spain.
Tobias LahmerMedizinische Klinik II, Klinikum Rechts der Isar, TU München, Munich, Germany.
Ľuboš DrgoňaComenius University and National Cancer Institute, Bratislava, Slovakia.
Maria MerelliAzienda Sanitaria Universitaria del Friuli Centrale, Udine, Italy.
Annarosa CuccaroHematology Unit, Center for Translational Medicine, AziendaUSL Toscana NordOvest, Livorno, Italy.
Sonia Martín-PérezHospital Nuestra Señora de Sonsoles, Ávila, Spain.
Julio Dávila-VallsHospital Nuestra Señora de Sonsoles, Ávila, Spain.
Francesca FarinaIRCCS Ospedale San Raffaele, Milan, Italy.
Chiara CattaneoHematology Unit, ASST-Spedali Civili, Brescia, Italy.
László Imre PinczésDivision of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
Ferenc MagyariDivision of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
Ildefonso EspigadoDepartment of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain.
Caterina BuquicchioEmatologia Con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy.ORCID 0000-0002-3683-5953
Donald C VinhMcGill University Health Centre, Montreal, Canada.
Igor StomaGomel State Medical University, Gomel, Belarus.
Martin ČerňanUniversity Hospital Olomouc, Olomouc, Czech Republic.
Lucia PreziosoHematology and Bone Marrow Unit, Hospital University of Parma, Parma, Italy.
Mario Virgilio PapaAzienda Ospedaliera Sant'Anna e San Sebastiano, Caserta, Italy.
Gaëtan PlantefeveHead ICU and CRC, Centre Hospitalier Victor DUPOUY, Argenteuil, France.
Reham Abdelaziz KhedrDepartment of Pediatric Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
Josip BatinićUniversity Hospital Centre Zagreb, Zagreb, Croatia.
Gabriele MaglianoASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
Simge ErdemDivision of Hematology, Department of Internal Medicine, Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Sofya KhostelidiNorth-Western State Medical University Named After Iliá Ilich Méchnikov, Saint-Petersburg, Russia.
Natasha ČolovićUniversity Clinical Center of Serbia, Belgrade, Serbia.
Davide NappiHematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura Dei Tumori (IRST) IRCCS, Meldola, Italy.ORCID 0000-0001-9776-5875
Patricia García-RamírezServicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Jakub GóraMedical University of Warsaw, Warszawa, Poland.
Marta Callejas-CharaviaServicio de Hematología y Hemoterapia, Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Spain.
Jędrzej TłustyMedical University of Warsaw, Warszawa, Poland.
Martijn BakkerUniversity Medical Center Groningen, Groningen, The Netherlands.
Elwira WojtyniakDepartment of Clinical Microbiology, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland.
Darko AntićUniversity Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0002-2608-1342
Agnieszka MagdziakDepartment of Clinical Microbiology, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland.
Michelina DargenioOspedale Vito Fazzi, Lecce, Italy.ORCID 0000-0003-0924-4629
Larisa IdrizovićFaculty of Medicine, University of Cologne and University Hospital Cologne, Institute of Translational Research, Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Nikola PantićUniversity Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0001-7798-4026
Zlate StojanoskiUniversity Clinic of Hematology, Skopje, North Macedonia.
Noha EisaFaculty of Medicine, Mansoura University, Mansoura, Egypt.
Vladimir OtaševićUniversity Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0002-8690-1357
Monia MarchettiHematology and Transplant Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.ORCID 0000-0001-7615-0572
Erica MackenzieUniversity of Kansas Medical Center, Kansas City, Missouri, USA.ORCID 0009-0000-1218-436X
Carolina Garcia-VidalDepartment of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.ORCID 0000-0002-8915-0683
Avinash AujayebNorthumbria Healthcare, Newcastle, UK.
Ahlam AlmasariKing Faisal Specialist Hospital, Jeddah, Saudi Arabia.
Carolina Miranda-CastilloHospital Rey Juan Carlos, Móstoles, Spain.
Eleni GavriilakiGeneral Hospital of Thessaloniki "George Papanikolaou", Thessaloniki, Greece.ORCID 0000-0002-8883-8208
Nicola CoppolaDepartment of Mental Health and Public Medicine, Universitry of Campania, Naples, Italy.
Alessandro BuscaStem Cell Transplant Center, AOU Cittá della Salute e della Scienza, Turin, Italy.
Tatjana Adžić-VukičevićUniversity Clinical Center of Serbia, Belgrade, Serbia.
Martin SchönleinDepartment of Oncology, Hematology and Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0002-1010-0975
Ditte Stampe HersbyDepartment of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
Stefanie K GräfeUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID 0000-0001-7678-0179
Andreas GlenthøjDepartment of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-2082-0738
Tommaso Francesco AielloDepartment of Infectious Diseases, Hospital Clinic de Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
Milche CvetanoskiUniversity Clinic of Hematology, Skopje, North Macedonia.
Mirjana MitrovićUniversity Clinical Center of Serbia, Belgrade, Serbia.ORCID 0000-0001-8313-3754
Claudio CerchioneHematology Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura Dei Tumori (IRST) IRCCS, Meldola, Italy.
Romane PrinCRA From CRC Centre Hospitalier Victor DUPOUY, Argenteuil, France.
Gina VarricchioAzienda Ospedaliera Sant'Anna e San Sebastiano, Caserta, Italy.
Elena ArellanoDepartment of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain.
Raúl CórdobaFundacion Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.
Jiří MayerDepartment of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.ORCID 0000-0003-0567-9887
Benjamín VíšekUniversity Hospital Hradec Králové, Hradec Králové, Czech Republic.
Dominik WolfDepartment of Hematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck (MUI), Innsbruck, Austria.
Amalia N AnastasopoulouLaikon Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.ORCID 0000-0002-2147-7583
Mario DeliaHematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.ORCID 0000-0002-6486-8912
Pellegrino MustoHematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.
Dario LeottaAOU Policlinico Rodolico San Marco, Catania, Italy.
Martina BavastroDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Alessandro LimongelliDepartment of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
Mariarita SciumèHematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.ORCID 0000-0001-7958-4966
Lukas van den VenFaculty of Medicine, University of Cologne and University Hospital Cologne, Institute of Translational Research, Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Luana FianchiHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.ORCID 0000-0002-7113-7202
Sara Caterina BrunettiHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.
Joanna Drozd-SokołowskaMedical University of Warsaw, Warszawa, Poland.
Anna Dąbrowska-IwanickaMaria Skłodowska-Curie Institute of Oncology, Warszawa, Poland.
Oliver A CornelyFaculty of Medicine, University of Cologne and University Hospital Cologne, Institute of Translational Research, Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany.
Livio PaganoHematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy.ORCID 0000-0001-8287-928X
Funding
No grant is acknowledged in the PubMed record.
Abstract
Community-acquired respiratory viral infections (CARV) significantly impact patients with hematological malignancies (HM), leading to high morbidity and mortality. However, large-scale, real-world data on CARV in these patients is limited. This study analyzed data from the EPICOVIDEHA-EPIFLUEHA registry, focusing on patients with HM diagnosed with CARV during the 2023-2024 autumn-winter season. The study assessed epidemiology, clinical characteristics, risk factors, and outcomes. The study examined 1312 patients with HM diagnosed with CARV during the 2023-2024 autumn-winter season. Of these, 59.5% required hospitalization, with 13.5% needing ICU admission. The overall mortality rate was 10.6%, varying by virus: parainfluenza (21.3%), influenza (8.8%), metapneumovirus (7.1%), RSV (5.9%), or SARS-CoV-2 (5.0%). Poor outcomes were significantly associated with smoking history, severe lymphopenia, secondary bacterial infections, and ICU admission. This study highlights the severe risk CARV poses to patients with HM, especially those undergoing active treatment. The high rates of hospitalization and mortality stress the need for better prevention, early diagnosis, and targeted therapies. Given the severe outcomes with certain viruses like parainfluenza, tailored strategies are crucial to improving patient outcomes in future CARV seasons.
Indexed as
Hematologic NeoplasmsRespiratory Tract InfectionsVirus DiseasesAdultAgedAged, 80 and overCommunity-Acquired InfectionsCOVID-19FemaleHospitalizationHumansInfluenza, HumanMaleMiddle AgedRegistriesRisk Factorsantiviral therapycommunity‐acquired respiratory viral infectionhematological malignancysecondary infectionvaccine coverage
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.